Filing Details

Accession Number:
0001209191-11-021318
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-04-04 20:36:21
Reporting Period:
2011-02-28
Filing Date:
2011-04-04
Accepted Time:
2011-04-04 20:36:21
Original Submission Date:
2011-03-09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1182129 Auxilium Pharmaceuticals Inc AUXL Pharmaceutical Preparations (2834) 233016883
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219866 Armando Anido C/O Auxilium Pharmaceuticals, Inc.
40 Valley Stream Parkway
Malvern PA 19355
Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-28 2,419 $22.47 13,653 No 4 F Direct
Common Stock Acquisiton 2011-03-08 5,280 $7.81 18,933 No 4 M Direct
Common Stock Disposition 2011-03-08 5,280 $23.01 13,653 No 4 S Direct
Common Stock Acquisiton 2011-03-08 5,275 $7.81 18,928 No 4 M Direct
Common Stock Disposition 2011-03-08 5,275 $23.03 13,653 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonqualified Stock Option (Right to Buy) Disposition 2011-03-08 10,555 $0.00 10,555 $7.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
388,890 2016-07-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 53,537 Indirect By 2010 GRAT
Common Stock 58,339 Indirect By 2009 GRAT
Common Stock 21,607 Indirect By 2008 GRAT
Footnotes
  1. Payment of tax liability by withholding shares incident to the vesting of restricted stock issued in accordance with Rule 16b-3.
  2. The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2010.
  3. The option fully vested on July 17, 2010.